Pluri Inc. Payments to Acquire Available-for-sale Securities
Pluri Inc. (PLUR) reported Payments to Acquire Available-for-sale Securities of $1.15 million for the 12-month period ending 2018-06-30, per its 10-K filed 2020-09-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2020-09-10
- Pluri Inc. payments to acquire available-for-sale securities for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- Pluri Inc. payments to acquire available-for-sale securities for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Pluri Inc. payments to acquire available-for-sale securities for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Pluri Inc. payments to acquire available-for-sale securities for the quarter ending 2017-09-30 was $1.15M, a 67.06% increase year-over-year.
- Pluri Inc. payments to acquire available-for-sale securities for fiscal 2018 was $1.15M, a 68.23% decline from fiscal 2017.
- Pluri Inc. payments to acquire available-for-sale securities for fiscal 2017 was $3.61M, a 14.42% decline from fiscal 2016.
- Pluri Inc. payments to acquire available-for-sale securities for fiscal 2016 was $4.21M, a 14.03% decline from fiscal 2015.
- Pluri Inc. payments to acquire available-for-sale securities for fiscal 2015 was $4.90M, a 54.82% decline from fiscal 2014.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2018-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-10 | $0.00 derived: sum of 2 quarters · filed 2020-09-10 | $0.00 derived: sum of 3 quarters · filed 2020-09-10 | $1.15M 10-K · filed 2020-09-10 |
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-06 | $0.00 derived: sum of 2 quarters · filed 2019-05-06 | $1.15M 10-Q · filed 2019-05-06 | $2.46M derived: sum of 4 quarters · filed 2019-09-12 |
| 2017-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-06 | $1.15M 10-Q · filed 2019-02-06 | $2.46M derived: sum of 3 quarters · filed 2019-09-12 | $3.19M derived: sum of 4 quarters · filed 2019-09-12 |
| 2017-09-30 | $1.15M 10-Q · filed 2018-11-07 | $2.46M derived: sum of 2 quarters · filed 2019-09-12 | $3.19M derived: sum of 3 quarters · filed 2019-09-12 | $4.07M derived: sum of 4 quarters · filed 2019-09-12 |
| 2017-06-30 | $1.31M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-12 | $2.04M derived: sum of 2 quarters · filed 2019-09-12 | $2.92M derived: sum of 3 quarters · filed 2019-09-12 | $3.61M 10-K · filed 2019-09-12 |
| 2017-03-31 | $730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-09 | $1.61M derived: sum of 2 quarters · filed 2018-05-09 | $2.29M 10-Q · filed 2018-05-09 | $2.55M derived: sum of 4 quarters · filed 2018-09-12 |
| 2016-12-31 | $876.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-06 | $1.56M 10-Q · filed 2018-02-06 | $1.82M derived: sum of 3 quarters · filed 2018-09-12 | $3.23M derived: sum of 4 quarters · filed 2018-09-12 |
| 2016-09-30 | $686.00K 10-Q · filed 2017-11-07 | $947.00K derived: sum of 2 quarters · filed 2018-09-12 | $2.36M derived: sum of 3 quarters · filed 2018-09-12 | $4.33M derived: sum of 4 quarters · filed 2018-09-12 |
| 2016-06-30 | $261.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-12 | $1.67M derived: sum of 2 quarters · filed 2018-09-12 | $3.64M derived: sum of 3 quarters · filed 2018-09-12 | $4.21M 10-K · filed 2018-09-12 |
| 2016-03-31 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-08 | $3.38M derived: sum of 2 quarters · filed 2017-05-08 | $3.95M 10-Q · filed 2017-05-08 | $5.33M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-12-31 | $1.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-08 | $2.54M 10-Q · filed 2017-02-08 | $3.92M derived: sum of 3 quarters · filed 2017-09-07 | $4.93M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-09-30 | $576.00K 10-Q · filed 2016-11-07 | $1.95M derived: sum of 2 quarters · filed 2017-09-07 | $2.97M derived: sum of 3 quarters · filed 2017-09-07 | $5.39M derived: sum of 4 quarters · filed 2017-09-07 |
| 2015-06-30 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $2.39M derived: sum of 2 quarters · filed 2017-09-07 | $4.81M derived: sum of 3 quarters · filed 2017-09-07 | $4.90M 10-K · filed 2017-09-07 |
| 2015-03-31 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | $3.44M derived: sum of 2 quarters · filed 2016-05-09 | $3.53M 10-Q · filed 2016-05-09 | $5.57M derived: sum of 4 quarters · filed 2016-09-07 |
| 2014-12-31 | $2.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-08 | $2.51M 10-Q · filed 2016-02-08 | $4.55M derived: sum of 3 quarters · filed 2016-09-07 | $5.46M derived: sum of 4 quarters · filed 2016-09-07 |
| 2014-09-30 | $92.00K 10-Q · filed 2015-11-05 | $2.13M derived: sum of 2 quarters · filed 2016-09-07 | $3.04M derived: sum of 3 quarters · filed 2016-09-07 | $6.08M derived: sum of 4 quarters · filed 2016-09-07 |
| 2014-06-30 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-07 | $2.95M derived: sum of 2 quarters · filed 2016-09-07 | $5.99M derived: sum of 3 quarters · filed 2016-09-07 | $10.85M 10-K · filed 2016-09-07 |
| 2014-03-31 | $905.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-06 | $3.95M derived: sum of 2 quarters · filed 2015-05-06 | $8.81M 10-Q · filed 2015-05-06 | $14.81M derived: sum of 4 quarters · filed 2015-09-09 |
| 2013-12-31 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-05 | $7.90M 10-Q · filed 2015-02-05 | $13.90M derived: sum of 3 quarters · filed 2015-09-09 | |
| 2013-09-30 | $4.86M 10-Q · filed 2014-11-06 | $10.86M derived: sum of 2 quarters · filed 2015-09-09 | ||
| 2013-06-30 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | $8.53M 10-K · filed 2015-09-09 | ||
| 2013-03-31 | $2.54M 10-Q · filed 2014-05-08 | |||
| 2012-06-30 | $8.16M 10-K · filed 2014-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |